Blog Posts

Important drugs such as Valium and Xanax function by affecting GABA (Gamma-Aminobutyric Acid), the main inhibitory neurotransmitter in the mammalian central nervous system. Professor Asher Brandt from University of Saint Joseph met Nanome scientists in virtual reality for a guided journey through the latest research on how the GABA-A receptor impacts pathological sleep in humans. Their session is now available on Youtube!

Collaborative work has become increasingly important in a variety of fields, from scientific research to design and engineering. However, working together remotely or in hybrid settings can be challenging, especially when it comes to XR environments. With the latest Nanome v1.24.4 patch, the platform has become even more user-friendly and streamlined for collaborative work. The new patch focuses on reducing the friction involved in setting up group sessions and loading content, making it easier and quicker than ever before to get started with collaborative work in Nanome. This improved functionality is set to revolutionize the way teams work together in XR, opening up new possibilities for research, design, and innovation. In this blog post, we'll explore the key improvements in the latest Nanome patch and how they will benefit users.

Discover the power of Nanome with its new innovative plugins and features designed to enhance drug discovery research. Explore Pymol integration, CryoEM, Antibody Representation, Conformer Generator, and more, alongside a seamless chat function and Quick Drop capabilities. Unlock new insights and drive breakthroughs in small molecule drug discovery, protein engineering, macromolecular design, and beyond with Nanome's cutting-edge tools.

The FDA recently approved Tzield, the first CD3-directed monoclonal antibody, which helps manage Type 1 Diabetes, and can delay the onset of symptoms by nearly three years. Nanome’s new VR plug-ins for biologics research make it easy for scientists to visualize, design, and simulate large molecules & complex biologics in 3D.

20 years and a vaccine for Lyme Disease is still in the works, but structural biology has another trick up its sleeve: Antibody Prophylaxis! We met with Dr. Mike Rudolph, senior scientist at NYSBC, in virtual reality to discuss his team's research on Lyme Disease.

AI is finally delivering on its promise to revolutionize drug discovery and development: a COVID-19 drug entirely designed by generative AI has been approved for human use and will soon begin clinical trials in China!

You can't catch a cold in virtual reality, but you can figure out how to stop the COVID-19 pandemic! Learn how scientists at the Oak Ridge National Laboratory designed an inhibitor for SARS-CoV-2 using virtual reality and a High Flux Isotope Reactor.

We’re thrilled to launch version 1.24 of Nanome alongside the Meta Quest Pro! Nanome 1.24 takes advantage of the Quest Pro’s hardware to deliver groundbreaking features such as Mixed Reality Passthrough for all-in-one devices, Meta Avatars, and more!

Toxic nerve agents have been used in war crimes, assassinations, and terrorist attacks. Thankfully, researchers at UCSD are leveraging virtual reality to develop antidotes. Virtual reality allows them to visualize acetylcholinesterase (AChE), the enzyme that nerve agents like sarin or VX attack.